From the Editor-in-Chief
still affecting our day-to-day lives. Everything, as a matter of fact, including the defense of our great country. As I write this column in early December, there is unrest in Belarus and Hong Kong; U.S troop drawdowns in Afghan- istan and Somalia; North Korea will probably test a missile soon and the South China Sea remains a contested area. You see, even though we are living through a pandemic and you still can’t go around without a mask on, that doesn’t mean the world suddenly became peaceful. Far from it.
W
Just as the world isn’t standing still, neither are our Soldiers. Tey are still deploying, conducting exercises and fighting around the world. Tey still need state-of-the-art equip- ment to do their jobs, which means our Army Acquisition Workforce members can’t take time off from the pandemic, either. Tis issue focuses on the numerous ways in which the various program executive offices, U.S. Army Futures Command and the Army Acquisition Workforce members running them are helping to thwart the pandemic by continuing to develop, acquire, field and sustain the world's best equipment and service to our troops.
It’s hard enough to produce what our Army needs during normal times. Now, mix in the pandemic, teleworking, observing strict social distancing, mask wearing, and you have gone from difficult to darn near impossible … but we’re doing it. Take, for example, the Joint Program Exec- utive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). Its whole mission is to prepare for the unimaginable. Now add to that— pandemic! Read how, as part of a DOD collaboration, it partnered with the U.S. Department of Health and Human Services to support vaccine development, thwart biological threats and navigate regulations. Agile acquisition meets agile execution at the U.S. Army Combat Capabilities Development Command (DEVCOM). Learn how Maj. Gen. John George pivoted his mission and put his team of 10,000 scientists and engineers to the task of keeping our
elcome to 2021! With multiple vaccines on the way and other therapeutics emerging, it has got to be better than 2020. But unfortunately COVID-19 is
Soldiers safe from COVID- 19 by training virus-sniffing dogs, producing face cover- ings, researching antibodies and even sending their own personal protection equip- ment downrange—all in an effort to protect our great- est asset, our Soldier. Finally, join the U.S. Army Medical Research and Development Command (USAMRDC) on the COVID-19 front lines and fight alongside the team at the forefront of the distribution of remdesivir— a broad-spectrum antiviral treatment developed by corporate partner Gilead Sciences Inc. With USAMRDC’s help, there is hope that DOD soon may be able to provide a tool to curb coronavirus infection for good.
Email Nelson McCouch III @
armyalt@mail.mil
Finally, I want to say thank you to the many Army AL&T magazine readers and subscribers, who are also our contrib- utors. Tis is my 10th year as the editor-in-chief. Te magazine has changed dramatically since I began, both in format and content. While online articles and social media have greatly expanded our audience, in the end, it’s the content that counts. Without you and the amazing content you provide, there would not be a magazine. Trough the years, my team of expert writers, graphic artists and editors have worked with literally thousands of experts and other contributors across the Army to provide superior articles and graphics. Because of your involvement, we have been able to highlight the great work taking place throughout Army acquisition, while keeping everyone apprised of lead- ership priorities.
Here’s to another 10 years of great stories, and of serving you. As always, if you have comments, story ideas or a story you would like to submit, please contact us at ArmyALT@
mail.mil. We look forward to hearing from you.
Nelson McCouch III Editor-in-Chief
https://asc.ar my.mil 3
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176
